QBTS Q1 2026 Earnings Narrowed Loss Beats Estimates Shares Surge Iveda Solutions Q2 2024 Earnings EPS Surpasses Estimates Despite Minimal Revenue Data ABUS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline OCFC Q1 2026 Earnings EPS Beats Expectations Amid Modest Share Decline GDS Q1 2026 Earnings Massive EPS Beat Defies Expectations Despite Stock Dip DH Q1 2026 Earnings Strong EPS Beat Drives Stock Higher BioAge Labs Q1 2026 Earnings Narrower Loss Delivers Positive Surprise as PreRevenue Biotech Advances Pipeline COLB Q1 2026 Earnings EPS Surpasses Expectations with 30 Beat Grid Dynamics GDYN Q1 2026 Earnings EPS Beats Estimates Amid Improved Profitability IMKTA Q1 2026 Earnings Strong EPS Performance Despite Modest Market Reaction WGRX Q1 2026 Earnings Heavy Loss and Steep Selloff as Transparency Remains Limited Immunocore IMCR Q1 2026 Earnings Stunning EPS Beat Masks Caution as Shares Slide 39